Search Within

Andrea Cercek Hanjis

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (60)
  2. Meeting Abstract (46)
  3. Miscellaneous (4)
  4. Editorial (1)
Groups
  1. Department of Medicine (111)
  2. GSK Faculty (111)
  3. Gastrointestinal Oncology Service (111)
  4. Human Oncology and Pathogenesis Program (111)
  5. Solid Tumor Oncology Division (111)
  6. Survivorship Research (111)

More Groups

People
  1. Nancy Kemeny (53)
  2. Michael D'Angelica (52)
  3. William Jarnagin (51)
  4. T Peter Kingham (45)
  5. Vinod Balachandran (43)
  6. Michael Berger (39)

More People

Years
  1. 2025 (6)
  2. 2024 (22)
  3. 2023 (13)
  4. 2022 (8)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. Annals of Surgical Oncology (21)
  3. Clinical Cancer Research (13)
  4. JNCI: Journal of the National Cancer Institute (4)
  5. Nature Medicine (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (35)
  2. Springer (22)
  3. American Association for Cancer Research (16)
  4. Elsevier Inc. (8)
  5. Oxford University Press (7)
  6. Wiley Blackwell (7)

More Publishers

Results (111)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BAP1 inactivation in mesothelioma is highly prevalent
    Meeting Abstract

    Zauderer, M.; Cercek, A.; Rimner, A.; Rusch, V.; Adusumilli, P. S.; Nash, G. M.; Moreira, A.; Hmeljak, J.; Ladanyi, M.; Krug, L. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Early onset colorectal cancer - Does the difference lie in epigenetics?
    Meeting Abstract

    Ben-Aharon, I.; Pelossof, R.; Elkabets, M.; Battaglin, F.; Goodman, K.; Yaeger, R.; Saltz, L.; Schultz, N.; Solit, D.; Garcia-Aguilar, J.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Confirmation of high prevalence of BAP1 inactivation in mesothelioma
    Meeting Abstract

    Cercek, A.; Zauderer, M. G.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Nash, G. M.; Hmeljak, J.; Ladanyi, M.; Krug, L. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Using mutational load in next generation sequencing (NGS) to identify mismatch repair (MMR) deficiency in colorectal cancer (CRC)
    Meeting Abstract

    Battaglin, F.; Stadler, Z. K.; Cercek, A.; Yaeger, R. D.; Segal, N. H.; Varghese, A. M.; Kemeny, N. E.; Weiser, M. R.; Garcia-Aguilar, J.; Shia, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients
    Journal Article

    Yaeger, R.; Cercek, A.; O'Reilly, E. M.; Reidy, D. L.; Kemeny, N.; Wolinsky, T.; Capanu, M.; Gollub, M. J.; Rosen, N.; Berger, M. F.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer
    Journal Article

    Cercek, A.; Shia, J.; Gollub, M.; Chou, J. F.; Capanu, M.; Raasch, P.; Reidy-Lagunes, D.; Proia, D. A.; Vakiani, E.; Solit, D. B.; more...
    Clinical Colorectal Cancer (2014)

    Fulltext@MSK | Save
  • Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
    Journal Article

    Brannon, A. R.; Vakiani, E.; Sylvester, B. E.; Scott, S. N.; McDermott, G.; Shah, R. H.; Kania, K.; Viale, A.; Oschwald, D. M.; Vacic, V.; more...
    Genome Biology (2014)

    Fulltext@MSK | Save
  • BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer
    Journal Article

    Yaeger, R.; Cercek, A.; Chou, J. F.; Sylvester, B. E.; Kemeny, N. E.; Hechtman, J. F.; Ladanyi, M.; Rosen, N.; Weiser, M. R.; Capanu, M.; more...
    Cancer (2014)

    Fulltext@MSK | Save
  • Comparative genomic analysis of primary versus metastatic colorectal carcinomas
    Journal Article

    Vakiani, E.; Janakiraman, M.; Shen, R.; Sinha, R.; Zeng, Z.; Shia, J.; Cercek, A.; Kemeny, N.; D'Angelica, M.; Viale, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer
    Meeting Abstract

    Misale, S.; Yaeger, R.; Hobor, S.; Scala, E.; Janakiraman, M.; Liska, D.; Valtorta, E.; Schiavo, R.; Buscarino, M.; Siravergna, G.; more...
    Annals of Oncology (2012)

    Fulltext@MSK | Save